Browse

You are looking at 31 - 40 of 49 items for :

  • Research and Innovation x
  • Refine by Content Type: All x
Clear All Modify Search
ASN Staff

KidneyX_logo.PNGThe KidneyX Summit kicked off on April 29, 2019, with opening remarks by ASN President Mark Rosenberg, MD, FASN, who outlined how KidneyX is filling a much-needed gap in kidney care and will act as a catalyst to spur innovation in the space.  Held at the United States Institute of Peace in Washington, DC, the summit will continue on April 30 with congressional perspectives; the role of NIH, FDA, and payors; and the nephrology investment landscape.

ASN Staff

The U.S. Department of Health and Human Services Office of the Chief Technology Officer and the American Society of Nephrology have selected 15 winning teams for Phase 1 of the KidneyX Redesign Dialysis prize competition.

During the inaugural KidneyX Summit which began today, April 29th, and continues to through April 30th, the winners were announced. The winners presented their solutions to an audience of industry leaders with government, mechanical and bioengineering, investment, and medical product development.

ASN Staff

logo_big_0.pngThe American Society of Nephrology (ASN) announced today that John R. Sedor, MD, FASN, has been appointed Chair of the Kidney Innovation Accelerator (KidneyX) Steering Committee. KidneyX is a public-private partnership between ASN and the U.S. Department of Health and Human Services (HHS). Dr. Sedor will lead the KidneyX Steering Committee to drive innovation and investment in the prevention, diagnosis, and treatment of kidney diseases.

Zachary Kribs

At the urging of the American Society of Nephrology (ASN) members and American Association of Kidney Patients (AAKP) ambassadors’ calls and recent visits to Capitol Hill, a bipartisan group of 57 lawmakers wrote to the House Appropriations Labor, Health and Human Services, and Education Subcommittee asking them to include $25 million in funding for KidneyX. The letter, sent March 28, represents a major victory for KidneyX and is the latest example of a recent outpouring of public support for KidneyX from Congress and the Administration. Congressional Kidney Caucus Co-Chairs Representative Suzan DelBene (D-WA-01) and Representative Larry Bucshon (R-IN-08), along with champions of patient-centered innovation, Representative Terri Sewell (D-AL-7) and Representative Brian Babin (R-TX-36), spearheaded the letter culminating the intensive efforts from congressional leaders and the kidney community.

ASN Staff

The American Society of Nephrology (ASN) and other members of the kidney community met with Health and Human Services (HHS) Secretary Alex M. Azar II and other top HHS officials in a roundtable on Friday, February 1 to discuss value-based kidney care transformation.

During the meeting, Secretary Azar, Centers for Medicare and Medicaid Innovation (CMMI) and Senior Advisor to the Secretary for Value-based Transformation and Innovation Director Adam Boehler, Assistant Secretary for Health Admiral Brett P. Giroir, MD, and Chief Technology Officer Ed Simcox, underscored the administration’s interest in improving the lives of people with kidney diseases, including efforts to increase access to transplantation. ASN underscored the society’s gratitude for their interest in transforming kidney care delivery for the 40 million Americans with kidney diseases and, together with the other participants, a strong willingness to work collaboratively to achieve shared goals.

Zach Cahill

The Kidney Health Initiative (KHI) recently released a new website to inform the community about its mission, objectives, and membership. The new site also showcases the publications from completed projects since the formation of KHI in 2012.

For the first time, KHI’s research and recommendations are centralized and accessible to kidney health professionals, researchers, patients, and innovators. The redesigned website highlights:

Zach Cahill

ima_thumb.pngIn early December 2018, Prabir Roy-Chaudhury, MD, PhD, FASN, the outgoing American Society of Nephrology Co-Chair for KHI, and Raymond C. Harris, MD, FASN, who began his term as Co-Chair for KHI in 2019, recorded a discussion with ASN Executive Vice-President Tod Ibrahim. This wide-ranging Kidney News podcast included Dr. Roy-Chaudhury’s evaluation of his six-year tenure and an outline of Dr. Harris’ vision for the future.

Zach Cahill

“What I have learned more than anything else, is that if you get talented and committed people from different backgrounds together, then wonderful and impactful things just seem to happen.” Prabir Roy-Chaudhury, MD, PhD, FASN, ASN Co-Chair for the Kidney Health Initiative

KHI is a public private partnership with the US Food and Drug Administration whose mission is to foster the development of new therapies to improve the lives of people living with kidney diseases. KHI has completed several projects this year, selected a new American Society of Nephrology (ASN) Co-Chair, and released a technology roadmap to outline opportunities for innovative alternatives to renal replacement therapy (RRT). Below are six highlights from the past year.

Zach Cahill

While dialysis is a life-saving therapy for patients with end stage kidney disease (ESKD), a variety of symptoms occur following treatment that significantly diminishes the quality of life of people living with kidney disease. A 2009 study published in the Clinical Journal of the American Society of Nephrology (CJASN) reported that patients on maintenance dialysis experience 11 unique symptoms. Patients have identified the need to alleviate these symptoms as a key research area, prioritizing it above other health outcomes. Alleviation of these symptoms could result in increased quality of life and better patient-reported outcome measures. Despite the patient demand for new therapies to address these symptoms, no drug or device has been approved by the US Food and Drug Administration (FDA) to date.

Zach Cahill

ttp _thumb_0.pngThe American Society Nephrology (ASN) is pleased to announce that Raymond C. Harris, MD, FASN, has been selected as the incoming ASN Co-Chair for the Kidney Health Initiative (KHI). Dr. Harris will serve a three-year term, starting in January 2019.  Dr. Harris will succeed Prabir Roy-Chaudhury, MD, PhD, FASN, who has served six years as KHI’s founding co-chair.